FTC’s proposed order requires Fresenius to divest 60 dialysis clinics to acquire Liberty Dialysis Holdings
The FTC has announced a proposed order requiring Fresenius Medical Care to divest 60 dialysis clinics before acquiring Liberty Dialysis Holdings. Fresenius operates more than 1,800 outpatient dialysis clinics in the U.S.; Liberty operates 260 dialysis centers. The divestitures would occur in Dallas and Anchorage. The FTC’s order also contains additional terms ensuring transion services for the divested clinics and places conditions on Fresenius’ activities with the clinics.
The settlement would resolve charges that the $2.1 billion deal would violate Section 5 of the FTC Act and Section 7 of the Clayton Act. According to the FTC, the acquisition would create monopolies for outpatient dialysis services in 17 of 43 local markets, and competition would be greatly diminished in the remaining markets.
Source: FTC Press Release
Related content: Observations on the Commission’s Evanston Remedy: When Is Divestiture, or Any Remedy, Not Appropriate for a Consummated Anticompetitive Merger? (Mark Botti, Akin Gump)
Featured News
Judge Dismisses Antitrust Lawsuit Against Ivy League Over Athletic Scholarships
Oct 11, 2024 by
CPI
FTC and DOJ Revamp Merger Guidelines to Identify Illegal Transactions More Efficiently
Oct 11, 2024 by
CPI
US Consumer Watchdog Eyes Expansion of ‘Junk Fee’ Crackdown Ahead of 2024 Election
Oct 10, 2024 by
CPI
Brazil Proposes Reform to Competition Law Targeting Big Tech
Oct 10, 2024 by
CPI
Meta Enhances User Data Control, Resolving German Antitrust Dispute
Oct 10, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Refusal to Deal
Sep 27, 2024 by
CPI
Antitrust’s Refusal-to-Deal Doctrine: The Emperor Has No Clothes
Sep 27, 2024 by
Erik Hovenkamp
Why All Antitrust Claims are Refusal to Deal Claims and What that Means for Policy
Sep 27, 2024 by
Ramsi Woodcock
The Aspen Misadventure
Sep 27, 2024 by
Roger Blair & Holly P. Stidham
Refusal to Deal in Antitrust Law: Evolving Jurisprudence and Business Justifications in the Align Technology Case
Sep 27, 2024 by
Timothy Hsieh